The largest community of pharma leaders

Puma Biotechnology Presents Efficacy and Safety Outcomes from the Phase III NALA Trial at the 2020 SABCS

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology presented efficacy and safety outcomes from the Phase III NALA Trial in a Spotlight Poster at the 2020 Virtual SABCS.

Source Business Wire Health: Pharmaceutical NewsRead More

Recent Articles